PT-141 (10mg) Sourcing Coordination for Clinics

PT-141 (Bremelanotide) Sourcing Coordination Services

PT-141 coordination

At Phoenix Meds Inc., we understand the growing interest in PT-141 (Bremelanotide). However, we also understand the administrative headache of sourcing it reliably, securely, and compliantly. Therefore, we act as your dedicated liaison, facilitating communication between your licensed clinic and licensed pharmacies and distributors across the US.

As a liaison service, we facilitate relationships between qualified clinics and licensed pharmacies or wholesalers—we do not prescribe, dispense, manufacture, or directly supply any pharmaceutical products.

For years, the default approach has been peripheral—targeting vascular pathways with PDE5 inhibitors or managing hormone levels. As many medical directors and practitioners recognize, intimacy is often influenced by both neurological and physiological factors.

PT-141 (Bremelanotide) represents an alternative therapeutic approach that operates through a different mechanism of action.

If you’re a medical director or clinic owner, we help your clinic operate more efficiently by removing the need for time-consuming communication with suppliers. This allows your team to focus on patient care while we simplify the coordination process without practicing medicine or directly providing medications.

PT-141 coordination

About PT-141 (Clinical Overview)

PT-141 sourcing for clinics

As reported in published research, PT-141, clinically known as Bremelanotide, is a novel agent in the treatment of sexual dysfunction. Unlike PDE5 inhibitors, which target the peripheral vasculature, PT-141 targets melanocortin receptors (MC4 receptors) and stimulates the central nervous system to increase sexual desire and arousal.

This treatment option may be of interest to prescribing physicians who manage patients unresponsive to traditional therapy or where cardiovascular contraindications may limit the use of certain oral ED medications.

This peptide is believed to primarily affect desire-related pathways rather than the mechanical aspects of sexual function. Bremelanotide is FDA-approved as Vyleesi for the treatment of acquired, generalized HSDD in certain premenopausal women. Some clinicians have also explored its use in other patient populations; however, all treatment decisions remain solely within the discretion of the prescribing provider.

In your practice, maintaining access to a dependable source for PT-141 can support operational continuity when serving appropriate patient populations, including premenopausal women with HSDD and other patients as determined by the treating provider.

PT-141 sourcing for clinics
medical supplier

Who this coordination is for?

We support US based appropriately licensed healthcare organizations, including:

If your clinic is evaluating PT 141 as part of a clinician directed care plan, we can coordinate introductions and documentation with suitable partners.

Disclaimer:

This is not medical advice and is not intended to recommend treatment for any individual. Clinical decisions including patient selection, counseling, dosing, contraindications, and monitoring must be made by the treating, licensed provider in accordance with current labeling, evidence, and professional standards.

Our Role in PT-141 Sourcing Support

PT-141 for both men and women

We are a 100% compliant sourcing coordinator.

Let’s make it very clear: 

PT-141 for both men and women
shipping states where Phoenix Meds reaches

Why Clinics Choose Our Coordination Services

Over the years we have developed partnerships with many medical directors and have identified a few key qualities they always look for:

Regulatory Clarity: As you are busy running a clinic, it’s difficult to keep up with every state pharmacy board regulation, all the compounding requirements, and shipping laws state to state. We have that information readily available and keep ourselves current.

Quality Control: Each one of our network partners has been vetted on sterility testing procedures, COA (Certificate of Analysis) availability, and storage of peptides. We will not bring on a partner who is not up to standard.

Open Communication: There are no pushy sales people or unrealistic offers; we tell you exactly what we can access, reasonable delivery times, and if something is limited.

Professional Confidentiality: Due to the nature of sexual wellness therapies, discretion is essential. Our coordination system understands the importance of patient confidentiality and professional ethics.

Coordination Process for PT-141 Sourcing for Clinics:

Complete the form below to initiate verification for your clinic. This service is available to licensed medical clinics only. All sourcing is handled exclusively by authorized third-party pharmacy and wholesale partners under applicable law.

Professional Verification

Register your clinic with Phoenix Meds Inc. by submitting your NPI/State Medical License for verification.

Sourcing Request

Once approved, select PT-141 from the category within our secure portal to view available coordination pathways.

Pharmacy Fulfillment

Your request is transmitted to a vetted pharmacy partner. The pharmacy processes the request and ships the compound directly to your facility.

Frequently Asked Questions

PT-141 Sourcing & Procurement Coordination for Clinics

Our 503A and 503B partner pharmacies can only source their PT-141 API from FDA registered facilities, assuring complete state board of pharmacy compliance and pharmaceutical grade purity.
Yes, every compounding partner in our network utilizes rigorous third party independent testing for sterility, endotoxins and potency of each batch. Batch specific COA’s are readily accessible to your medical staff, for purposes of regulatory and compliance records.
We coordinate for both options depending on the particular needs of your state board of pharmacy and clinic volume. Our organization matches you with 503A pharmacies for patient direct shipments, as well as licensed 503B outsourcing facilities for compliant office use.
Yes, because it is an active ingredient in an FDA-approved medication and is not on the FDA’s Do Not Compound list. Our compliance team stays current with all changes in legislation and is there to protect your prescribing practices.
BUD is decided on by the specific formulation pharmacy based on USP<797> guidance and specific stability testing. Typically lyophilized vials are designed for much longer expiration than reconstituted vials which have very strictly regulated BUDs
Most of our vetted partner pharmacies turn around orders in 24-48 hours after prescription approval by your clinic. Most patients receive their compounded medication via express shipping in 3-5 business days.
Although the primary responsibility of patient care falls on your clinic, all formal AE tracking and reporting to the FDA is performed by the licensed compounding pharmacy, protecting your medical license and the patient in a shared compliance model.
Scroll to Top